This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2014 Sep 25;371(13):1249-51.

doi: 10.1056/NEJMe1408614. Epub 2014 Sep 8.

Anti-interleukin-5 monoclonal antibody to treat severe eosinophilic asthma

Parameswaran Nair¹

Affiliations

PMID: 25197762
DOI: 10.1056/NEJMe1408614

Editorial

Anti-interleukin-5 monoclonal antibody to treat severe eosinophilic asthma

Parameswaran Nair. N Engl J Med. 2014.

. 2014 Sep 25;371(13):1249-51.

doi: 10.1056/NEJMe1408614. Epub 2014 Sep 8.

Author

Parameswaran Nair¹

Affiliation

¹ From the Division of Respirology, McMaster University, Hamilton, ON, Canada.

PMID: 25197762
DOI: 10.1056/NEJMe1408614

No abstract available

PubMed Disclaimer

Comment on

Mepolizumab treatment in patients with severe eosinophilic asthma.
Ortega HG, Liu MC, Pavord ID, Brusselle GG, FitzGerald JM, Chetta A, Humbert M, Katz LE, Keene ON, Yancey SW, Chanez P; MENSA Investigators. Ortega HG, et al. N Engl J Med. 2014 Sep 25;371(13):1198-207. doi: 10.1056/NEJMoa1403290. Epub 2014 Sep 8. N Engl J Med. 2014. PMID: 25199059 Clinical Trial.
Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.
Bel EH, Wenzel SE, Thompson PJ, Prazma CM, Keene ON, Yancey SW, Ortega HG, Pavord ID; SIRIUS Investigators. Bel EH, et al. N Engl J Med. 2014 Sep 25;371(13):1189-97. doi: 10.1056/NEJMoa1403291. Epub 2014 Sep 8. N Engl J Med. 2014. PMID: 25199060 Clinical Trial.

Similar articles

Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab.
Pelaia C, Vatrella A, Busceti MT, Gallelli L, Terracciano R, Savino R, Pelaia G. Pelaia C, et al. Drug Des Devel Ther. 2017 Oct 30;11:3137-3144. doi: 10.2147/DDDT.S150656. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 29133975 Free PMC article. Review.
Glucocorticoids and mepolizumab in eosinophilic asthma.
Iikura M, Hojo M, Sugiyama H. Iikura M, et al. N Engl J Med. 2014 Dec 18;371(25):2433-4. doi: 10.1056/NEJMc1412892. N Engl J Med. 2014. PMID: 25517713 No abstract available.
Glucocorticoids and mepolizumab in eosinophilic asthma.
Lindsay JT, Heaney L. Lindsay JT, et al. N Engl J Med. 2014 Dec 18;371(25):2433. doi: 10.1056/NEJMc1412892. N Engl J Med. 2014. PMID: 25517712 No abstract available.
Glucocorticoids and mepolizumab in eosinophilic asthma.
Bel EH, Ortega HG, Pavord ID. Bel EH, et al. N Engl J Med. 2014 Dec 18;371(25):2434. doi: 10.1056/NEJMc1412892. N Engl J Med. 2014. PMID: 25517711 No abstract available.
Pharmacokinetic drug evaluation of mepolizumab for the treatment of severe asthma associated with persistent eosinophilic inflammation in adults.
Kallur L, Gonzalez-Estrada A, Eidelman F, Dimov V. Kallur L, et al. Expert Opin Drug Metab Toxicol. 2017 Dec;13(12):1275-1280. doi: 10.1080/17425255.2017.1406919. Expert Opin Drug Metab Toxicol. 2017. PMID: 29157020 Review.

See all similar articles

Cited by

Saudi Arabian real-life experience with biologic therapy in severe asthma.
Eldaboussi S, Qabil A, Lotfi A, Awad A, Abdel Salam E, Alkhamis A, Abuelhassan UE. Eldaboussi S, et al. Multidiscip Respir Med. 2021 Dec 29;16(1):807. doi: 10.4081/mrm.2021.807. eCollection 2021 Jan 15. Multidiscip Respir Med. 2021. PMID: 35070293 Free PMC article.
Role of Biologics in Asthma.
McGregor MC, Krings JG, Nair P, Castro M. McGregor MC, et al. Am J Respir Crit Care Med. 2019 Feb 15;199(4):433-445. doi: 10.1164/rccm.201810-1944CI. Am J Respir Crit Care Med. 2019. PMID: 30525902 Free PMC article. Review.
Eosinophils Target Therapy for Severe Asthma: Critical Points.
Brussino L, Heffler E, Bucca C, Nicola S, Rolla G. Brussino L, et al. Biomed Res Int. 2018 Oct 25;2018:7582057. doi: 10.1155/2018/7582057. eCollection 2018. Biomed Res Int. 2018. PMID: 30498762 Free PMC article. Review.
New targets for resolution of airway remodeling in obstructive lung diseases.
Nayak AP, Deshpande DA, Penn RB. Nayak AP, et al. F1000Res. 2018 May 30;7:F1000 Faculty Rev-680. doi: 10.12688/f1000research.14581.1. eCollection 2018. F1000Res. 2018. PMID: 29904584 Free PMC article. Review.
Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab.
Pelaia C, Vatrella A, Busceti MT, Gallelli L, Terracciano R, Savino R, Pelaia G. Pelaia C, et al. Drug Des Devel Ther. 2017 Oct 30;11:3137-3144. doi: 10.2147/DDDT.S150656. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 29133975 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information